- Home
- Daily Diary
- Asset Class
- Sector
- Latest
- Author
- Street Notes
- TheStreet
- Switch to
-0.03| Last Update: 05/24/13 - 4:00 PM EDT |
| Volume: 3,131,575 |
| YTD Performance: 21.31% |
| Open: $48.56 |
| Previous Close: $48.76 |
| 52 Week Range: $32.80 - $50.69 |
| Oustanding Shares: 468,643,839 |
| Market Cap: 22,851,073,590 |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $1.09 | $0.95 | $4.75 | $5.13 |
| Number of Analysts | 18 | 17 | 20 | 20 |
| High Estimate | $1.37 | $1.12 | $5.15 | $5.55 |
| Low Estimate | $0.72 | $0.79 | $4.39 | $4.80 |
| Prior Year | $0.87 | $1.46 | $4.36 | $4.75 |
| Growth Rate (Year over Year) | 24.71% | -35.17% | 9.05% | 7.93% |
Caution has clearly been the fool’s way in this market.
Some of the health insurers have posted strong results in the first quarter.
Allstate added to Conviction Buy List at GoldmanALL was placed on the Conviction Buy list, according to Goldman Sachs. Company appears to be firing on all cylinders.
Let's take a good look at other members of this space -- an insurer and a transaction processor.
Several major insurance firms are still selling under book value.
BofA/Merrill Insurance Conf.
Allstate estimates, target raised at MKMShares of ALL now seen reaching $55, according to MKM Partners. Estimates also increased, given better expected homeowners' results. Buy rating.
Allstate estimates lowered at UBSALL estimates lowered through 2012, UBS said. Sandy loss modestly above expectations. Neutral rating and $40 price target.
I can see where people would fade any all-out market strength.